To accelerate biotechnology innovations, such as the development of lifesaving drug therapies, scientists strive to develop faster, more quantitative, and more widely available ways to observe biomolecules in living cells. Now, for the first time ever, NIST scientists have developed a new method that captures clear images of biomolecules in single live cells using infrared (IR) transmission imaging. The method has the potential to speed up advances in biomanufacturing, cell therapy development and drug development. Learn more about the imaging technique in our news story: https://lnkd.in/eWWD-i4k #Microscopy #Imaging #AnalyticalChemistry #Bioscience
National Institute of Standards and Technology (NIST)’s Post
More Relevant Posts
-
𝐋𝐮𝐦𝐢𝐧𝐢𝐜𝐞𝐥𝐥 𝐔𝐧𝐯𝐞𝐢𝐥𝐬 𝐑𝐞𝐛𝐫𝐚𝐧𝐝: 𝐂𝐄𝐋𝐋𝐀𝐑𝐈𝐒™ – 𝐘𝐨𝐮𝐫 𝐒𝐭𝐞𝐥𝐥𝐚𝐫 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐅𝐥𝐮𝐨𝐫𝐞𝐬𝐜𝐞𝐧𝐜𝐞 𝐂𝐞𝐥𝐥 𝐋𝐚𝐛𝐞𝐥𝐥𝐢𝐧𝐠 Cellaris (formerly known as Luminicell Tracker™), was inspired by a desire to capture the true essence of the technology, as well as the spirit of advancement it represents. The team at Luminicell believe in pushing the boundaries of research discoveries with their stellar performing products. Cellaris reflects not only the product's primary application in cell-related research, but also draws a parallel to the brilliance, high performance and long-lasting nature associated with stars. 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐨𝐟 𝐂𝐞𝐥𝐥𝐚𝐫𝐢𝐬: 🌟 𝐒𝐭𝐞𝐥𝐥𝐚𝐫 𝐏𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 Unprecedented long-lasting and bright signal 🌟 𝐒𝐭𝐚𝐭𝐞-𝐨𝐟-𝐭𝐡𝐞-𝐀𝐫𝐭 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 Biocompatible fluorescence nanoparticles powered with unique fluorophores that comes with aggregation-induced emission (AIE) characteristics 🌟 𝐄𝐧𝐚𝐛𝐥𝐢𝐧𝐠 𝐁𝐢𝐨𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 Designed to address the demanding needs of translational research topics such as cell therapy, drug discovery, 3D model and tissue construct applications. Learn more about Cellaris: https://luminicell.com/ Read the official release here: https://lnkd.in/gd2C5BAD #Luminicell #Cellaris #LiveCell #FluorescenceImaging #Stellar #FluorescenceFriday #FluorescentFriday #LuminicellTracker #Rebranding
To view or add a comment, sign in
-
Cell Sorting Magnetic Beads Nanometer-sized cell sorting magnetic beads can be used for sorting human cells by conjugating anti-human monoclonal antibodies to the magnetic beads, facilitating the sorting of target cells. These beads incubate with peripheral blood mononuclear cells (PBMCs) or bone marrow samples and undergo magnetic separation to enrich and isolate target cells, thus purifying them. VDO Biotech introduces a new series of sorting magnetic beads, including CD4, CD8, CD138, and SA sorting beads, to meet the diverse needs of customers in various scenarios. CD4/CD8 sorting beads are efficient tools for cell separation, commonly used in scientific research to precisely separate or enrich CD4+/CD8+ T cells. This technology facilitates researchers in studying the functions and mechanisms of T cell subsets in-depth. Inquire us at [email protected]
To view or add a comment, sign in
-
Now available In Press and #OpenAccess: 'Bioreactor on a chip: A microfluidic device for closed production of human dendritic cells' from Kevin Loutherback, Peggy Bulur, and Allan Dietz. In this article, they share a novel platforming utilizing microfluidics to isolate, count, identify and culture cells in a closed, cGMP-compatible manner. The scalability and closed nature of the chip give it the potential to be a novel method used for cell therapy industrialization and rapid manufacturing. https://lnkd.in/gZzaKHaa
To view or add a comment, sign in
-
From Breaking Bad to Biotechnology: Exploring the New Frontier Join us as we dive into the fascinating world of biotechnology, from the iconic TV series Breaking Bad to the latest advancements in cell therapy. Discover how purified antibodies are revolutionizing medicine and how this cutting-edge field combines both passion and practicality. #BreakingBad #Biotechnology #CellTherapy #MedicalAdvancements #PurifiedAntibodies #ScienceAndTechnology #BiotechRevolution #MedicalInnovation #CellularResearch #HealthcareAdvances
To view or add a comment, sign in
-
HumaTein™ a cell culture biomaterial supplement consisting of full native human ECM (Extracellular Matrix), useful for in vitro 4D bioprinting and cell culturing as well as clinical translational studies @RokitHealthcare https://buff.ly/4bGTZBs #organregeneration#skinregeneration
To view or add a comment, sign in
-
From Breaking Bad to Biotechnology: Exploring the New Frontier Join us as we dive into the fascinating world of biotechnology, from the iconic TV series Breaking Bad to the latest advancements in cell therapy. Discover how purified antibodies are revolutionizing medicine and how this cutting-edge field combines both passion and practicality. #BreakingBad #Biotechnology #CellTherapy #MedicalAdvancements #PurifiedAntibodies #ScienceAndTechnology #BiotechRevolution #MedicalInnovation #CellularResearch #HealthcareAdvances
To view or add a comment, sign in
-
Biophysical tools are powerful as they provide robust and reliable data, and can be applied to many stages across drug discovery workflows. Watch this on-demand webinar from Eurofins Cerep to learn how they use biophysics to carry out fragment screens and develop targeted protein degraders. You’ll get insight into how they: 💡 Used nanoDSF to confirm that their target protein, PIM3, was well-folded and intact so they could generate reproducible data 💡 Chose Spectral Shift technology over SPR after comparing binding data of a reference compound to the target 💡 Applied the same assay design to measure both low-affinity fragment binding and high-affinity PROTAC binding Watch the webinar: https://ow.ly/5SA150Rz3OE
Biophysics in kinase drug discovery: FBS to PROTAC® ternary complex characterisation
https://www.youtube.com/
To view or add a comment, sign in
-
Spectral Shift technology is already changing how CROs are doing business. Watch this video to see how they decide which screening method gives the most reliable and trustworthy results.
Biophysical tools are powerful as they provide robust and reliable data, and can be applied to many stages across drug discovery workflows. Watch this on-demand webinar from Eurofins Cerep to learn how they use biophysics to carry out fragment screens and develop targeted protein degraders. You’ll get insight into how they: 💡 Used nanoDSF to confirm that their target protein, PIM3, was well-folded and intact so they could generate reproducible data 💡 Chose Spectral Shift technology over SPR after comparing binding data of a reference compound to the target 💡 Applied the same assay design to measure both low-affinity fragment binding and high-affinity PROTAC binding Watch the webinar: https://ow.ly/5SA150Rz3OE
Biophysics in kinase drug discovery: FBS to PROTAC® ternary complex characterisation
https://www.youtube.com/
To view or add a comment, sign in
-
Navigating the Challenges of iPSC Differentiation: The Advantages of Tubular Bowl Centrifuges in Media Exchange In the rapidly evolving field of regenerative medicine, the cultivation of induced pluripotent stem cells (iPSCs) represents a cornerstone of therapeutic innovation. iPSCs hold unparalleled potential for disease modeling, drug discovery, and the development of cell therapies, owing to their ability to differentiate into any cell type. However, the translation of iPSC technology from bench to commercial bioproduction hinges on the development and implementation of scalable, efficient, and cell-friendly bioprocessing techniques. Here we introduce a novel approach to media exchanges, employing a tubular bowl centrifuge to address the critical requirements for media exchange during iPSC cultivation. https://lnkd.in/gZkzG2aY #aspenalert #biotech #bioprocess
To view or add a comment, sign in
-
New review outlining the progress of #nanoparticle delivery technologies to deliver therapeutics across the #BloodBrainBarrier, including #PolymericNanoparticles, #dendrimers, #LipidNanoparticles and inorganic nanoparticles. A major challenge of the space is that most major nanoparticle carriers accumulate in major organs such as the liver, spleen, lungs and kidneys. The intricate interactions between therapeutic nanomaterials, the immune system, and biological barriers are also still not fully understood. There are also experimental challenges in evaluating brain-targeting NP formulations, issues with scaling, regulation, and clinical validation. Do we think nanoparticle delivery will emerge as a viable technology for the treatment of brain disorders? It has a lot of ground to make on other non-viral BBB penetrant delivery technologies, such as bioconjugate shuttles. Full paper: https://lnkd.in/g26vHZBn
To view or add a comment, sign in
358,554 followers
NIST scientists have introduced a groundbreaking method using infrared (IR) transmission imaging to capture clear images of biomolecules in single live cells. This innovative approach promises to significantly accelerate biotechnology advancements, including drug therapies and cell therapy development. By providing a more detailed view of biomolecular interactions in real-time, this method could enhance biomanufacturing processes and speed up the development of lifesaving treatments.